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INTRODUCTION
Several rickettsial diseases have been reported in
the Mediterranean basin, including Mediterra-
nean spotted fever, caused by Rickettsia conorii
and transmitted by Rhipicephalus sanguineus ticks,
tick-borne lymphadenopathy, caused by Rickettsia
slovaca and transmitted by Dermacentor marginatus
ticks, Rickettsia mongolitimonae infection, transmit-
ted by Hyalomma spp. ticks, Rickettsia helvetica
infection, transmitted by Ixodes ricinus ticks, and
ﬂea-borne spotted fever, caused by Rickettsia felis
and transmitted by cat ﬂeas (Ctenocephalides felis)
[1]. Since 2003, prospective surveillance and
serological and molecular diagnosis of rickettsi-
oses in the Trakya Region of Turkey has been
conducted by the Trakya University in Edirne and
the Universite´ de la Mediterrane´e in Marseille
[1,2]. In 2003 and 2004, 22 patients were diag-
nosed as spotted fever group (SFG) rickettsioses,
using molecular diagnostic methods [1,2]. R. co-
norii was previously isolated from the skin biopsy
specimens of three of ten patients, and was also
demonstrated by PCR in skin biopsy specimens of
nine of ten patients [1]. From May to September
2005, 24 patients with SFG rickettsioses were
admitted into the Trakya University Hospital, a
tertiary-care hospital in Edirne. In this prospec-
tive study, our aim was to isolate and identify the
rickettsial strains from skin biopsy specimens and
blood samples of these 24 patients diagnosed with
spotted fever in the Trakya Region of Turkey in
2005.
MATERIALS AND METHODS
SFG rickettsioses were diagnosed according to the criteria for
MSF in ‘Guidelines for the diagnosis of tick-borne bacterial
diseases in Europe’ [3]. SFG rickettsioses were diagnosed
clinically on the basis of clinical signs such as high fever,
maculopapular rash (may include palms or soles), headache,
myalgia, arthralgia, and ⁄or a unique eschar (the tache noire) at
the tick bite site. The patients ﬁlled out questionnaires about
tick exposure and the presence of symptoms or signs consis-
tent with acute tick-borne rickettsioses. Three blood samples
were taken from each patient on admission into the hospital
for total blood cell count, biochemistry analysis, and serologi-
calal testing. Two weeks later, another sample was taken to
obtain convalescent-phase serum. Before treatment, punch
biopsy from skin lesions was performed. Serum specimens
were tested by microimmunoﬂuorescence (MIF) assay using
either commercially available antigens (R. conorii IFA IgG;
Focus Technologies, USA) or an in-house MIF using a panel of
nine rickettsial antigens, including R. conorii, R. helvetica,
R. slovaca, Rickettsia massiliae, Rickettsia aeschlimannii, Rickettsia
sibirica subsp. mongolitimonae, R. conorii subsp. israelensis,
R. felis and Rickettsia typhi, as previously described [1]. DNA
was extracted from skin biopsy specimens using the QIAamp
DNA Mini Kit (Qiagen, Hilden, Germany). Standard PCR was
performed with primers suitable for hybridization within the
conserved region of genes coding for outer membrane pro-
tein A (ompA) and citrate synthase (gltA) [1,3].
RESULTS
The average age of the 24 patients (11 males and
13 females) was 54 ± 20 years. All the patients
had a high fever; 22 of the 24 patients (91.6%) had
maculopapular rash and rash in the palms or on
the soles. Fifteen patients had a unique eschar,
and two had double eschars (70.8%). Two
patients without maculopapular rash had an
eschar at the tick bite site. One patient had
arthritis at the right wrist. Two patients presented
with multiple organ failure, and one of them died.
This fatal case had a clinical score of 26 but had no
serological conﬁrmation (ﬁrst serum 0 ⁄ 64; second
serum could not be obtained, as the patient died)
[3]. Another patient presented with acute menin-
gitis and petechial rash. Twenty patients (83.3%)
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had signiﬁcant antibody titres against SFG rick-
ettsiae. PCR experiments were positive in seven
(53.8%) of 13 biopsy specimens from tache noire,
and sequences were 100% similar to that of
R. conorii subsp. conorii.
DISCUSSION
The Trakya Region (includes the cities Edirne,
Kırklareli, Tekirdag) is an endemic area for
rickettsioses, with a population of one million,
excepting Istanbul. Patients diagnosed as having
Mediterranean spotted fever were also reported
from Istanbul [4]. Since 2001, 59 patients have
been diagnosed as having SFG rickettsioses in the
Trakya Region [1,2,5]. Serious life-threatening
presentations of rickettsioses such as gastrointes-
tinal bleeding (1.7%), pneumonia (1.7%), menin-
gitis (3.4%), and multiple organ failure (6.8%),
and rare presentations such as temporary hearing
loss (1.7%) and arthritis (1.7%), can be observed.
Especially in elderly patients, multiple organ
failure causes death of the patients (two of the
four patients with multiple organ failure).
Differential diagnosis of tick-borne diseases is
important in Turkey, as Crimean-Congo haemor-
rhagic fever has also been reported since 2003.
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